Pancreatic carcinoma
RecruitingStudy of personalized FOLFIRINOX drug combination dosing (fluorouracil, irinotecan, oxaliplatin, and calcium folinate) for patients with pancreatic cancer
Study of personalized FOLFIRINOX drug combination dosing (fluorouracil, irinotecan, oxaliplatin, and calcium folinate) for patients with pancreatic cancer
- Disease:Pancreatic carcinoma
- Substances:Calcium FolinateFluorouracil+2
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Calcium Folinate
- Sponsor:Catharina Ziekenhuis Stichting











